SCHEMBL16102102

SCHEMBL16102102

NC(=O)/C(=C\c1ccccc1)c1ncc2ccccc2n1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 7/20 0.48
MAPT P10636 7/20 0.48
MEN1 O00255 6/20 0.48
ALDH1A1 P00352 5/20 0.48
KDM4E B2RXH2 5/20 0.48
HPGD P15428 1/20 0.48
PDE10A Q9Y233 1/20 0.43
CYP1A2 P05177 2/20 0.43
CYP3A4 P08684 2/20 0.43
CYP2D6 P10635 2/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
SMN1; SMN2 Q16637 5/20 0.40
GAA P10253 3/20 0.40
RAB9A P51151 5/20 0.40
RECQL P46063 1/20 0.40
AKR1C1 Q04828 1/20 0.39
MCL1 Q07820 1/20 0.39
LMNA P02545 3/20 0.38
NPC1 O15118 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30040032 0.84 MAP3K5 (0.37) KMT2AMAPTALDH1A1KDM4ECYP1A2
SCHEMBL30040835 0.84 MAP3K5 (0.37) KMT2AMAPTALDH1A1KDM4ECYP1A2
SCHEMBL5014075 0.80 KMT2A (0.38) KMT2AMAPTMEN1ALDH1A1KDM4E
SCHEMBL21777089 0.77 AKR1C1 (0.47) KMT2AMAPTMEN1ALDH1A1KDM4E
SCHEMBL10559629 0.77 IKBKB (0.41) MAPTALDH1A1KDM4EHPGDCYP1A2
SCHEMBL30931995 0.77 AKR1C1 (0.47) KMT2AMAPTMEN1ALDH1A1KDM4E
SCHEMBL422040 0.76 IKBKB (0.47) MAPTALDH1A1KDM4EHPGDCYP1A2
SCHEMBL29668334 0.76 IKBKB (0.47) MAPTALDH1A1KDM4EHPGDCYP1A2
SCHEMBL16101600 0.76 MGAM (0.59) KMT2AMAPTMEN1ALDH1A1KDM4E
Hydrochloric Acid SCHEMBL14843117 0.75 IKBKB (0.46) MAPTALDH1A1KDM4EHPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2968339-A1 MK2 INHIBITORS AND USES THEREOF Celgene Avilomics Research, Inc. (US) 2016-01-20 EP disclosed
WO-2014149164-A1 MK2 INHIBITORS AND USES THEREOF CELGENE AVILOMICS RESEARCH, INC. (US) 2014-09-25 WO disclosed